BioCentury | Oct 13, 2014
Clinical News

Stool DNA colorectal cancer screening assay regulatory update

...of the vimentin (VIM) gene. Under a 2009 deal, Exact Sciences has rights from the Mayo Foundation for Medical Education and Research...
BioCentury | Aug 18, 2014
Clinical News

Stool DNA colorectal cancer screening assay regulatory update

...is expected in October or November. FDA’s approval triggered a $500,000 milestone payment to the Mayo Foundation for Medical Education and Research...
BioCentury | Aug 12, 2014
Company News

Cologuard gets green light from FDA, CMS

...average risk of developing colorectal cancer. FDA's approval triggers a $500,000 milestone payment to the Mayo Foundation for Medical Education and Research...
BioCentury | Aug 31, 2009
Politics, Policy & Law

Doctoring the Lilly Doctrine

...based on lack of enablement or anticipation, for example. He cited Elan Pharmaceuticals Inc. v. Mayo Foundation for Medical Education and Research...
...NYSE:LLY), Indianapolis, Ind. Harvard University , Cambridge, Mass. Massachusetts Institute of Technology , Cambridge, Mass. Mayo Foundation for Medical Education and Research...
BioCentury | Oct 8, 2007
Company News

Cellumen, Mayo Foundation for Medical Education and Research deal

...assay will be jointly owned. Further terms were not disclosed. Cellumen Inc. , Pittsburgh, Penn. Mayo Foundation for Medical Education and Research...
BioCentury | May 21, 2007
Company News

Accentia, Mayo Foundation for Medical Education and Research deal

...deal with the foundation (see BioCentury, July 31, 2006). Accentia Biopharmaceuticals Inc. (ABPI), Tampa, Fla. Mayo Foundation for Medical Education and Research...
BioCentury | Nov 6, 2006
Company News

Clinical Data, Mayo Foundation for Medical Education and Research deal

...the IP to develop a test for that variant. Clinical Data Inc. (CLDA), Newton, Mass. Mayo Foundation for Medical Education and Research...
BioCentury | Feb 20, 2006
Company News

Laboratory Corp. of America Holdings, Mayo Foundation for Medical Education and Research sales and marketing update

...under a deal with the Mayo Foundation. Laboratory Corp. of America Holdings (LH), Burlington, N.C. Mayo Foundation for Medical Education and Research...
BioCentury | Jul 19, 2004
Company News

Accentia pharmaceuticals news

...formulation of amphotericin B to treat chronic rhinosinusitis. Accentia acquired intranasal amphotericin B from the Mayo Foundation for Medical Education and Research...
BioCentury | Jul 14, 2004
Company News

Investor group forms Accentia

...formulation of amphotericin B to treat chronic rhinosinusitis. Accentia acquired intranasal amphotericin B from the Mayo Foundation for Medical Education and Research...
Items per page:
1 - 10 of 16
BioCentury | Oct 13, 2014
Clinical News

Stool DNA colorectal cancer screening assay regulatory update

...of the vimentin (VIM) gene. Under a 2009 deal, Exact Sciences has rights from the Mayo Foundation for Medical Education and Research...
BioCentury | Aug 18, 2014
Clinical News

Stool DNA colorectal cancer screening assay regulatory update

...is expected in October or November. FDA’s approval triggered a $500,000 milestone payment to the Mayo Foundation for Medical Education and Research...
BioCentury | Aug 12, 2014
Company News

Cologuard gets green light from FDA, CMS

...average risk of developing colorectal cancer. FDA's approval triggers a $500,000 milestone payment to the Mayo Foundation for Medical Education and Research...
BioCentury | Aug 31, 2009
Politics, Policy & Law

Doctoring the Lilly Doctrine

...based on lack of enablement or anticipation, for example. He cited Elan Pharmaceuticals Inc. v. Mayo Foundation for Medical Education and Research...
...NYSE:LLY), Indianapolis, Ind. Harvard University , Cambridge, Mass. Massachusetts Institute of Technology , Cambridge, Mass. Mayo Foundation for Medical Education and Research...
BioCentury | Oct 8, 2007
Company News

Cellumen, Mayo Foundation for Medical Education and Research deal

...assay will be jointly owned. Further terms were not disclosed. Cellumen Inc. , Pittsburgh, Penn. Mayo Foundation for Medical Education and Research...
BioCentury | May 21, 2007
Company News

Accentia, Mayo Foundation for Medical Education and Research deal

...deal with the foundation (see BioCentury, July 31, 2006). Accentia Biopharmaceuticals Inc. (ABPI), Tampa, Fla. Mayo Foundation for Medical Education and Research...
BioCentury | Nov 6, 2006
Company News

Clinical Data, Mayo Foundation for Medical Education and Research deal

...the IP to develop a test for that variant. Clinical Data Inc. (CLDA), Newton, Mass. Mayo Foundation for Medical Education and Research...
BioCentury | Feb 20, 2006
Company News

Laboratory Corp. of America Holdings, Mayo Foundation for Medical Education and Research sales and marketing update

...under a deal with the Mayo Foundation. Laboratory Corp. of America Holdings (LH), Burlington, N.C. Mayo Foundation for Medical Education and Research...
BioCentury | Jul 19, 2004
Company News

Accentia pharmaceuticals news

...formulation of amphotericin B to treat chronic rhinosinusitis. Accentia acquired intranasal amphotericin B from the Mayo Foundation for Medical Education and Research...
BioCentury | Jul 14, 2004
Company News

Investor group forms Accentia

...formulation of amphotericin B to treat chronic rhinosinusitis. Accentia acquired intranasal amphotericin B from the Mayo Foundation for Medical Education and Research...
Items per page:
1 - 10 of 16